These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9546514)

  • 1. Aplastic anaemia during treatment with fluoxetine.
    Bosch X; Vera M
    Lancet; 1998 Apr; 351(9108):1031. PubMed ID: 9546514
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary Retention in an Adolescent Patient Caused by Fluoxetine Alone.
    Karadag M; Gokcen C; Bayar H; Aksoy I
    J Child Adolesc Psychopharmacol; 2015 Oct; 25(8):658. PubMed ID: 26485088
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluoxetine: therapeutic and undesirable effects.
    Cookson J; Duffett R
    Hosp Med; 1998 Aug; 59(8):622-6. PubMed ID: 9829055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sertraline-induced enuresis in a prepubertal child resolves after switching to fluoxetine.
    Maalouf FT; Gilbert AR
    J Child Adolesc Psychopharmacol; 2010 Apr; 20(2):161-2. PubMed ID: 20415614
    [No Abstract]   [Full Text] [Related]  

  • 5. Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder.
    López-Ibor JJ; Saiz J; Cottraux J; Note I; Viñas R; Bourgeois M; Hernández M; Gómez-Pérez JC
    Eur Neuropsychopharmacol; 1996 May; 6(2):111-8. PubMed ID: 8791036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inability to cry during SRI treatment.
    Oleshansky MA; Labbate LA
    J Clin Psychiatry; 1996 Dec; 57(12):593. PubMed ID: 9010124
    [No Abstract]   [Full Text] [Related]  

  • 7. Aripiprazole Treatment for Obsessive Compulsive Disorder in 2 Young Subjects Who Could Not Tolerate Selective Serotonin Reuptake Inhibitors (SSRIs).
    Coskun M; Karayagmurlu A
    J Clin Psychopharmacol; 2020; 40(3):310-312. PubMed ID: 32332471
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fluoxetine-induced tics in a child].
    Ceylan MF; Akca ÖF
    Turk Psikiyatri Derg; 2011; 22(1):61-2. PubMed ID: 21416809
    [No Abstract]   [Full Text] [Related]  

  • 9. Possible interaction of tramadol and antidepressants.
    Reus VI; Rawitscher L
    Am J Psychiatry; 2000 May; 157(5):839. PubMed ID: 10784494
    [No Abstract]   [Full Text] [Related]  

  • 10. Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
    Maina G; Albert U; Salvi V; Bogetto F
    J Clin Psychiatry; 2004 Oct; 65(10):1365-71. PubMed ID: 15491240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial.
    Geller DA; Hoog SL; Heiligenstein JH; Ricardi RK; Tamura R; Kluszynski S; Jacobson JG;
    J Am Acad Child Adolesc Psychiatry; 2001 Jul; 40(7):773-9. PubMed ID: 11437015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Fluoxetine on Obsessive-Compulsive Behaviors in Children and Adolescents With Autism Spectrum Disorders: A Randomized Clinical Trial.
    Reddihough DS; Marraffa C; Mouti A; O'Sullivan M; Lee KJ; Orsini F; Hazell P; Granich J; Whitehouse AJO; Wray J; Dossetor D; Santosh P; Silove N; Kohn M
    JAMA; 2019 Oct; 322(16):1561-1569. PubMed ID: 31638682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin reuptake inhibitor treatment of obsessive-compulsive symptoms in clozapine-medicated schizophrenia.
    Andrade C
    J Clin Psychiatry; 2012 Nov; 73(11):e1362-4. PubMed ID: 23218164
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of fluoxetine on various subtypes of obsessive-compulsive disorder.
    Farnam A; Goreishizadeh MA; Farhang S
    Arch Iran Med; 2008 Sep; 11(5):522-5. PubMed ID: 18759519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study.
    Bergeron R; Ravindran AV; Chaput Y; Goldner E; Swinson R; van Ameringen MA; Austin C; Hadrava V
    J Clin Psychopharmacol; 2002 Apr; 22(2):148-54. PubMed ID: 11910259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder.
    Diniz JB; Shavitt RG; Fossaluza V; Koran L; Pereira CA; Miguel EC
    J Clin Psychopharmacol; 2011 Dec; 31(6):763-8. PubMed ID: 22020357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amotivational syndrome associated with selective serotonin reuptake inhibitors in children and adolescents.
    Garland EJ; Baerg EA
    J Child Adolesc Psychopharmacol; 2001; 11(2):181-6. PubMed ID: 11436958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Obsessive-compulsive symptoms in schizophrenia: remission with anti-obsessive treatment].
    Payá González B; Crespo Facorro B; Sáenz Herrero M; Ayuso Gutiérrez JL
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(3):201-3. PubMed ID: 9717345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Side effects as predictors of drug response in obsessive-compulsive disorder.
    Ackerman DL; Greenland S; Bystritsky A
    J Clin Psychopharmacol; 1999 Oct; 19(5):459-65. PubMed ID: 10505588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine-Induced "Rabbit Syndrome" in a Child With Juvenile Obsessive-Compulsive Disorder.
    Naguy A; Moodliar-Rensburg S; Elsori DH; Alamiri B
    Am J Ther; 2022 May-Jun 01; 29(3):e363-e364. PubMed ID: 32384313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.